Телеграмм чат группы sci

всем привет! в этом году международный конкурс по синтетической биологии iGEM проходит онлайн и поэтому появляется уникальная возможность послушать доклады бесплатно и из дома, а не за 900$ в Бостоне.
Зарегаться можно здесь: https://www.eventbrite.com/e/igem-2020-virtual-giant-jamboree-tickets-125398561473

Информация о событии здесь:
https://2020.igem.org/Giant_Jamboree

Программа:
November 13: Welcome Ceremony
November 14-16: Competition Days
November 17-20: Community Week
November 21: Contribution Day
November 22: Celebration Day

Выступление команды Moscow:
Presentation: November 15, 17:30 по Москве
Poster: Session D (November 15, 19:30-21:00 по Москве)- Building 2, Floor 4, Poster Number 130

Eventbrite

iGEM 2020: Virtual Giant Jamboree

Join us for 10 days of iGEM through Competition, Community, Contribution and Celebration!

источник

12:09пожаловаться #11

MB

Max Bokov in Science FYI

Anna Gribkova

всем привет! в этом году международный конкурс по синтетической биологии iGEM проходит онлайн и поэтому появляется уникальная возможность послушать доклады бесплатно и из дома, а не за 900$ в Бостоне.
Зарегаться можно здесь: https://www.eventbrite.com/e/igem-2020-virtual-giant-jamboree-tickets-125398561473

Информация о событии здесь:
https://2020.igem.org/Giant_Jamboree

Программа:
November 13: Welcome Ceremony
November 14-16: Competition Days
November 17-20: Community Week
November 21: Contribution Day
November 22: Celebration Day

Выступление команды Moscow:
Presentation: November 15, 17:30 по Москве
Poster: Session D (November 15, 19:30-21:00 по Москве)- Building 2, Floor 4, Poster Number 130

Eventbrite

iGEM 2020: Virtual Giant Jamboree

Join us for 10 days of iGEM through Competition, Community, Contribution and Celebration!

Международный конкурс iGEM - независимая некоммерческая организация, основанная в 2003 году в MIT, открывает свои двери для всех желающих, которые хотят принять участие и посмотреть как проходит конкурс.

Конкурс нацелен на:
1) Популяризацию науки, в частности, синтетической биологии, инженерии, IT и тд.
2) Создание и реализацию участниками проектов, которые решают конкретную задачу
3) Популяризации образования
4) Организацию открытого сообщества людей, которые впоследствии собираются в коллаборации.

В конкурсе принимают участие школьники и студенты разных профориентаций и компетенций (бакалавр, магистратура, аспирантура).

Более подробно о конкурсе и о пользе для участников можно узнать тут:
http://www.bio.msu.ru/news/view.php?ID=3257

Теперь желающие могут увидеть своими глазами как проходит Jamboree, какие интересные и амбициозные проекты представляются и другие детали внутренней кухни абсолютно бесплатно. Достаточно зайти на сайт, прочитать инструкцию проведения мероприятий и зарегистрироваться. Ранее билеты стоили 900 долларов за человека, но, в этом году для зрителей сделали исключение.

В этом году Россию представляют 2 команды (от МГУ и от РНИМУ им. Н.И. Пирогова)

Первая команда:

Presentation: November 15, 17:30 по Москве
Poster: Session D (November 15, 19:30-21:00 по Москве)- Building 2, Floor 4, Poster Number 130

Вторая команда:

Presentation:
November 15, 18.30 по мск
Poster:
November 15, 19.30-21.00 по мск, Session D, Building 3, Floor 4, Poster Number 132

Вы можете регистрироваться, окунуться в атмосферу самого масштабного конкурса по синтетической биологии и поддержать ребят!

Регистрация и более подробная информация по конкурсу:

https://2020.igem.org/Giant_Jamboree

Ждем вас!

источник

13:03пожаловаться #12

MB

Max Bokov in Science FYI

источник

13:03пожаловаться #13

M

M in Science FYI

sticker.webp

(44.86 Кб)

источник

13:11пожаловаться #14

M

M in Science FYI

А давно учёных ловили на конфликте интересов, которые они НЕ указали в статье, и выписывали из науки?

источник

13:11пожаловаться #15

V

VAS in Science FYI

Ведимир

Господа и дамы, вопрос.
У меня есть сразу две лабы, в которых я очень хотел бы оказаться на ПхД. В одной из них я сейчас пишу master thesis, в ней мне очень нравится научрук и тематика исследований (Таллин), в другую просто хочется до офигения и у есть ряд уникального оборудования/спецов (Берлин). Лабы давно и плотно взаимодействуют.
Засим вопрос - реально ли писать ПхД в двух лабах одновременно, если у них нету совместной graduate school?

плюсую, что можно просто спросить у лаб.

источник

13:52пожаловаться #16

SV

Semen Vasilev in Science FYI

PRESENTATION BY
Professor Rainer Fischer
Purdue University

TOPIC
Plant-based Biopharmaceuticals: How to Move New Product Candidates Towards Translational Research and the Market

WHEN
Friday, 13 November at 2.00pm

Register to join this webinar at:
https://us02web.zoom.us/webinar/register/WN_Ah07Kw69S_yz6xI-PUHawQ

DESCRIPTION
The development of recombinant antibodies and vaccines has allowed us to treat and prevent a large number of life-threatening diseases. However, as things stand in late 2020, the speed, capacity and scalability of current production systems is beginning to place limitations on this crucial technology. The large-scale production of antibodies, vaccines and other pharmaceutical recombinant proteins is restricted by the industry’s current reliance on fermenter technology, particularly the culture of mammalian cells. This expensive and time-consuming production platform is preventing the distribution of recombinant protein drugs to those most in need. One way in which the above limitations can be addressed is through the use of plants and plant-based expression systems for rapid recombinant pharmaceutical protein production. We have also developed an interesting multi-stage malaria vaccine and neutralizing rabies antibody candidates and will discuss how these products have matured over the years both in performance and in manufacturing with the aim in mind to bring these two products into translational research within the next months. Finally state of the art technology developments to accelerate the development and production of PMPs as well as regulatory issues will be discussed. Along this line an innovative new manufacturing concept using LED lighting in a vertical farm concept has been developed.

ABOUT THE PRESENTER
Rainer Fischer, Ph.D., was named Senior Executive for Innovation and Discovery in April 2019. Fischer joined the Indiana Biosciences Research Institute (IBRI) in April of 2017 as the Chief Scientific and Innovation Officer. In October that same year, he also was named Chief Executive Officer. Fischer spent 19 years building and leading the Fraunhofer Institute for Molecular Biology and Applied Ecology (IME) in Aachen, Schmallenberg, Muenster, Giessen, Frankfurt and Hamburg in Germany, and its subsidiaries in Newark, Delaware, USA and Santiago, Chile. The Fraunhofer-Gesellschaft is the largest applied science research organization in Europe, with applied research aimed at addressing issues of health, security, production technology, energy, materials, and the environment.
During his time at the Fraunhofer-Gesellschaft, Fischer grew the IME Institute from 40 to 680 employees, raised with his team almost one billion euro in extramural research funding, and established international collaborations with academia and industry in more than 25 countries. Those collaborations include many of the leading global companies in the biotechnology, pharmaceuticals, agriculture, food and chemical industries.
Fischer also served as Department Head of the Institute for Molecular Biotechnology at RWTH Aachen University where he was awarded a Distinguished Professorship in 2015. He created the department, co-establishing both undergraduate and graduate programs that have matriculated more than 500 students including 137 graduated Ph.D. students. Fischer is a prolific presenter and has published more than 420 peer-reviewed scientific papers and book chapters that have been cited almost 20,000 times.
In addition to his academic and leadership experience, he co-founded five biotechnology startups, holds over 50 issued patents and has more than 100 patent applications pending. Fischer also holds a second Professorship at Maastricht University, Netherlands where he co-founded the Aachen-Maastricht-Institute-of-Biobased-Materials (AMIBM) in 2015. In 2018, he was appointed Presidential Fellow and Research Professor at Purdue University.

Zoom Video

Welcome! You are invited to join a webinar: PLANT-BASED BIOPHARMACEUTICALS: HOW TO MOVE NEW PRODUCT CANDIDATES TOWARDS TRANSLATIONAL RESEARCH AND THE MARKET. After registering, you will receive a confirmation email about joining the webinar.

The development of recombinant antibodies and vaccines has allowed us to treat and prevent a large number of life-threatening diseases. However, as things stand in late 2020, the speed, capacity and scalability of current production systems is beginning to place limitations on this crucial technology. The large-scale production of antibodies, vaccines and other pharmaceutical recombinant proteins is restricted by the industry’s current reliance on fermenter technology, particularly the culture of mammalian cells. This expensive and time-consuming production platform is preventing the distribution of recombinant protein drugs to those most in need. One way in which the above limitations can be addressed is through the use of plants and plant-based expression systems for rapid recombinant pharmaceutical protein production. We have also developed an interesting multi-stage malaria vaccine and neutralizing rabies antibody candidates and will discuss how these products have matured over the years both in performance…